help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vella, V.
Right arrow Articles by Belfiore, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vella, V.
Right arrow Articles by Belfiore, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 6 2880-2889
Copyright © 2004 by The Endocrine Society

Interleukin-4 Stimulates Papillary Thyroid Cancer Cell Survival: Implications in Patients with Thyroid Cancer and Concomitant Graves’ Disease

Veronica Vella, Rossana Mineo, Francesco Frasca, Emanuela Mazzon, Giuseppe Pandini, Riccardo Vigneri and Antonino Belfiore

Istituto di Medicina Interna e di Malattie Endocrine e del Metabolismo (V.V., R.M., F.F., G.P., R.V.), Cattedra di Endocrinologia, University of Catania, Ospedale Garibaldi, 95123 Catania, Italy; Dipartimento di Biomorfologia e Biotecnologia (E.M.), University of Messina, Torre Biologica, Policlinico Universitario, 98122 Messina, Italy; and Dipartimento di Medicina Sperimentale e Clinica (A.B.), Cattedra di Endocrinologia, University of Catanzaro, Policlinico Mater Domini, 88100 Catanzaro, Italy

Address all correspondence and requests for reprints to: Antonino Belfiore, M.D., Dipartimento di Medicina Sperimentale e Clinica, Cattedra di Endocrinologia, Università di Catanzaro, Policlinico Mater Domini, via Tommaso Campanella, 115-88100 Catanzaro, Italy. E-mail: belfiore{at}unicz.it.

IL-4, a pleiotropic cytokine mainly produced by activated helper T lymphocytes type 2 (Th2), is known to protect thyroid cells from autoimmune damage. Acting via its receptors (IL-4R{alpha}), IL-4 has antiproliferative and apoptotic effects in many malignancies. Its effect in thyroid cancer is unknown.

We found that surgical specimens of thyroid carcinomas express both IL-4R{alpha} and IL-4 in the majority of cases. Thyroid glands affected by Graves’ disease also express IL-4. We also studied a panel of eight thyroid cancer cell lines from different histotypes and found that thyroid cancer cells express high levels of IL-4R{alpha} although they do not express IL-4.

We then compared the biological effects of IL-4 in TPC-1, a thyroid cancer cell line, and in MCF-7 breast cancer cells. IL-4 very weakly stimulated thyroid cancer cell proliferation, but it was very effective in protecting thyroid cancer cells from apoptosis induced by staurosporin. The protective effect of IL-4 was similar in magnitude to that of IGF-I and was associated with up-regulation of the antiapoptotic molecule Bcl-2 and weak down-regulation of the proapoptotic molecule Bax. Moreover, IL-4 slightly potentiated the survival effect of IGF-I. In contrast, IL-4 reduced growth and induced apoptosis in MCF-7 cells.

Taken together, these findings suggest that thyroid cancer cells receive significant protection from apoptosis by IL-4 produced in the thyroid gland by activated T lymphocytes when concomitant Graves’ disease is present.

This work was supported, in part, by the Associazione Italiana per la Ricerca sul Cancro (to A.B. and R.V.) and Ministero dell’Università e della Ricerca Scientifica e Tecnologica (Cofin 2003 to A.B.).

V.V. is the recipient of a fellowship from Fondazione Italiana per la Ricerca sul Cancro. F.F. is the recipient of a fellowship from the American Italian Cancer Foundation.

Abbreviations: CDK, Cyclin-dependent kinase; cFLIP, cellular FLICE-inhibitory protein; FBS, fetal bovine serum; IL-4R, IL-4 receptors; MTT, methyl thiazolyl tetrazolium; SDS, sodium dodecyl sulfate; TSAb, antibodies to the TSH receptor.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
L. H. Wei, Y. Yang, G. Wu, and L. J. Ignarro
IL-4 and IL-13 upregulate ornithine decarboxylase expression by PI3K and MAP kinase pathways in vascular smooth muscle cells
Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1198 - C1205.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Poncin, B. Lengele, I. M. Colin, and A.-C. Gerard
Differential Interactions between Th1/Th2, Th1/Th3, and Th2/Th3 Cytokines in the Regulation of Thyroperoxidase and Dual Oxidase Expression, and of Thyroglobulin Secretion in Thyrocytes in Vitro
Endocrinology, April 1, 2008; 149(4): 1534 - 1542.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. Aoudjehane, P. Podevin, O. Scatton, P. Jaffray, I. Dusanter-Fourt, G. Feldmann, P.-P. Massault, L. Grira, A. Bringuier, B. Dousset, et al.
Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway
FASEB J, May 1, 2007; 21(7): 1433 - 1444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society